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Microcin 7 is a small peptide produced and excreted to the culture medium by stationary-phase Escherichia
coli cells harboring the pMccC7 plasmid (formerly named pRYC7). This peptide inhibited the growth of the
enterobacteria phylogenetically closer to E. coli, apparently by blocking protein biosynthesis. The molecule was
degraded with trypsin, and the resulting fragments were purified and sequenced. The results show that
microcin 7 is a linear heptapeptide blocked at both ends.
Microcins are dialyzable (i.e., low-molecular-weight) an-
tibacterial agents originally found in bacterial isolates from
the feces of newborn infants (1). Most of the microcins seem
to be peptides, and, unlike the classical bacteriocins, they
are not inducible by agents that trigger the SOS system for
DNA repair (for a review, see reference 4).
The synthesis of microcins is not lethal for the producer
cells, and it requires the presence of plasmids specific for
each type of microcin (3, 21). Five such microcin types have
been characterized so far. In each case, the microcinogenic
plasmid is also implicated in the expression of the immunity
that the producer strains show to their own microcins, even
when the microcins are added exogenously (4).
Free microcin-like substances have been found in fecal
samples, and microcin-producing strains tend to predomi-
nate in patients with jejunal bacterial overgrowth. Further-
more, the colonization ability of Escherichia coli K-12 given
orally to Swiss mice is clearly enhanced by microcinogenic
plasmids (4). These results, together with the high diffusi-
bility and in some cases the resistance of microcins to
intestinal proteases, have led us to propose a role for these
compounds in the displacements of bacterial populations
that take place in the intestine under both normal and
pathological conditions (2). Bacteriocins are no longer
thought to play a role in such ecological successions (15), but
as we mentioned above, microcins do not look like classical
bacteriocins. As a matter of fact, they share properties with
both bacteriocins and the secondary-metabolism antibiotics.
These peculiar features of microcins and their presence in
the human intestinal ecosystem drew our attention to these
substances, and we chose microcin 7 (or C7 according to the
last proposals [4]) for further studies. Since there were only
scarce and indirect data on the chemical structure of micro-
cins, we undertook the purification and analysis of microcin
7. The molecule was purified from the supematants of
stationary cultures of E. coli RYC25 and was found to
contain seven different amino acids at the most, which
accounted for the apparent molecular weight as estimated by
gel filtration chromatography (11).
In the present work we report the amino acid sequence of
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the peptide (hence the first structural information on a
microcin), the spectrum of its antimicrobial activity, and the
first data on its mode of action.
MATERIALS AND METHODS
Trypsin treated with diphenylcarbamyl chloride, carboxy-
peptidase Y, phenylthiohydantoin amino acids, and Poly-
brene were purchased from Sigma Chemical Co., St. Louis,
Mo. Carboxypeptidases A and B and aminopeptidase M
were from E. Merck, Darmstadt, Federal Republic of Ger-
many. High-pressure liquid chromatography (HPLC) sol-
vents were of research standard, American Chemical Society
quality from Carlo Erba, Milan, Italy. Water was deionized
and distilled in glass over potassium permanganate. The
reagents and solvents for the sequencer and amino acid
analyzer were from Beckman Instruments Espafia, Madrid,
Spain. L-Methionyl-L-arginine was from Serva, Heidelberg,
Federal Republic of Germany, and the radioactive com-
pounds were from Amersham Corp., Arlington Heights, Ill.
All other chemicals were analytical grade products commer-
cially available.
All bacterial strains used were from the collection of the
Servicio de Microbiologia, Centro Ram6n y Cajal, Madrid,
Spain.
Tryptic digestions. Microcin 7 was obtained and purified
by HPLC as described previously (11). The lyophilized
peptide was dissolved in 0.4 M ammonium bicarbonate (pH
7.6, 0.5 nmol/,ul) and incubated with trypsin at 37°C
(enzyme/substrate ratio, 1 ,ug/100 nmol). The reaction was
stopped at the desired time by the addition of an equal
volume of 0.2% trifluoracetic acid and lyophilization of the
digestion mixture.
Carboxypeptidase digestions. Tryptic peptides (3 to 5 nmol)
were digested with carboxypeptidases under the following
conditions: (i) 4 U of carboxypeptidase A in 50 RI of 0.2 M
N-methylmorpholine, pH 8.2; (ii) 4 U of carboxypeptidase B
in 50 RI of the same buffer as above; (iii) 9 U of carboxy-
peptidase Y in 25 ,ul of 0.1 M pyridine-acetic acid, pH 5.5.
Digestions were carried out at 37°C for 15 h, and they were
stopped by lyophilization of the digestion mixture. The dry
material was suspended in 0.2 M sodium citrate buffer, pH
2.2, and applied to the amino acid analyzer.
Aminopeptidase M digestion. Tryptic peptide Td (6 to 15
nmol) was digested with aminopeptidase M (enzyme/
substrate ratio, 1 ,ug/nmol) in 50 ,ul of either 0.4 M ammo-
nium bicarbonate, pH 7.6, or 0.1 M potassium phosphate,
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pH 7.0. The digestions were carried out at 37°C, and
they were stopped at the desired times by lyophilization.
The products were analyzed for amino acids as described
above.
Amino acid analyses. The samples were hydrolyzed in
evacuated and sealed glass tubes at 110°C for 18 h with 200
,ul of 5.7 N HCI containing 0.02% (vol/vol) 2-mercaptoeth-
anol. The analyses were performed in a Beckman 121-M
analyzer equipped with a 126 Data System Integrator.
Sequencing procedures. The selected tryptic peptides were
sequenced by the manual Edman procedure (9). The method
of Edman and Begg (8) for automatic sequencing was also
followed, with a model 890-D Beckman sequencer and the
standard Beckman 0.1 M Quadrol program. To reduce
peptide washout, 3 ml of Polybrene was added when the
sample was applied to the cup (26). Amino acidic residues
were identified in the amino acid analyzer, after back hydrol-
ysis of the corresponding aniliniothiazolinone at 150°C for 4
h with 5.7 N HCl containing 0.1% (wt/vol) SnCl (18). Amide
assignments were made by converting a fraction (70%) of the
thiazolinone obtained in a given step to phenylthiohydantoin
(13). The phenylthiohydantoin amino acids were identified
by thin-layer chromatography on cellulose plates with an
incorporated fluorescent dye (Merck). Elution was per-
formed in the same direction with a first system composed of
n-heptane-propionic acid-1,2-dichloroethane (70:20:50,
vol/vol/vol) and a second system composed of chloroform-
methanol (87:13, vol/vol). The spots were visualized by
fluorescence quenching at 254 nm.
HPLC. Microcin 7 and its tryptic peptides were purified
with an HPLC system composed of M-6000A and M-45
pumps, an M-660 solvent delivery system, and an M-441 UV
multiwavelength absorbance detector, all from Waters As-
sociates, Milford, Mass. Samples were dissolved in 0.1%
(vol/vol) trifluoroacetic acid and applied either to a
,uBondapak-C18 column (0.4 by 30 cm; 10-,um mean particle
size) from Waters or to a Lichrosorb RP-18 column (0.4 by
25 cm; 5-,um mean particle size) from Merck. In both cases,
a guard column (270-,u volume) packed with Bondapak-
C18-Porasil B (Waters) was used. All chromatographic runs
were done at room temperature with a flow rate of 1 ml/min.
Detection was carried out at 206 or 214 nm.
Acylation ofL-Met-L-Arg. The commercial dipeptide L-Met-
L-Arg was formylated essentially as described previously
(24), but with the following modifications. A 10-mg amount
of the dipeptide in 60 RI of 98% formic acid was treated at
room temperature with a total of 20 RI of acetic anhydride,
distributed over five additions in the course of 1 h. After one
additional hour at room temperature, the mixture was lyoph-
ilized, and the formylated dipeptide was purified by HPLC.
The N-acetyl derivative was prepared as described else-
where (17), and the reaction products were also fractionated
by HPLC.
Incorporation of labeled precursors into macromolecules.
E. coli GS7T1 was used as the microcin-susceptible bacteria
in the labeling experiments. This strain is a spontaneous
thymine auxotroph isolated by us using trimethoprim (19) to
select it from E. coli GS7 (F-araD139 AlacU169 relA rpsL
thi malE7::TnS) (12), which is the parental strain of the strain
used as microcin producer (11). Strain GS7T1 was routinely
grown at 37°C in minimal medium M9 (19) supplemented
(per milliliter) with thiamine (10 ,ug), L-leucine (10 ,ug),
D,L-(+)-meso-diaminopimelic acid (10 ,ug), L-lysine (50 pLg),
uridine (20 ,ug), thymine (50 pLg), streptomycin (100 ,ug) and
kanamycin (20 ,ug). After reaching the mid-logarithmic phase
of growth (optical density at 660 nm [OD60] = 0.50), the
culture was diluted 1:10 with the same medium and allowed
to grow until ODw was 0.15. At that time, 6-ml portions of
the culture were transferred to prewarmed 125-ml Erlen-
meyer flasks, and the incubation was continued with strong
agitation until the medium in the flasks reached an OD660 of
0.20 (1.8 x 108 CFU/ml). Each flask then received 25 RI of
sterile water, with or without microcin 7 (final concentra-
tion, 0.4 nmol/ml), and one of the following labeled com-
pounds (per microgram): [methyl-3H]thymine (349 1jRCi),[6-3H]uridine (102 1QCi), D,L-(+)-meso-2,6-diamino[G-
3H]pimelic acid (2.19 ,uCi), D,L-[4,5-3H]leucine (211 jiCi), or
[U-_4C]leucine (2.3 ,uCi).
To measure the incorporation of label into DNA, RNA,
and proteins, the appropriate precursors were added at a
final concentration (per milliliter) of 10 ,uCi, 0.5 ,uCi, and 0.5
,uCi, respectively. Duplicate 200-,u samples were taken at
regular intervals and deposited in tubes containing 3 ml of
5% trichloroacetic acid (TCA) and kept in an ice bath. The
tubes with samples from the culture labeled with leucine
were boiled for 15 min to hydrolyze any charged tRNAs. In
every case, the precipitated material was collected on What-
man GF/C filters which were washed with 30 ml of ice-cold
5% TCA, dried, placed into a scintillation fluid composed of
5.5 g of Permablend (Packard Instrument Co., Inc., Rock-
ville, Md.) per liter of toluene, and counted in a Beckman
LS-2800 scintillation counter.
Tritiated diaminopimelic acid at a final concentration of 10jig and 10 ,uCi/ml was used to label cell walls. In this case,
each 200-pI sample was deposited in a tube containing 3 ml
of 4% sodium dodecyl sulfate and kept in a boiling-water
bath for 30 min. After being cooled, the insoluble material
was collected on HAWP filters (0.45-,um pore size; Millipore
Corp., Bedford, Mass.), washed with 30 ml of distilled
water, and counted as described above.
The incorporation rate of leucine and uridine during 2-min
pulses was measured essentially under the same conditions,
except for the volume of the cultures, which was scaled up
10 times. At the desired times, duplicate 0.9-ml samples from
the control and microcin-treated cultures were transferred to
tubes containing 0.1 ml of prewarmed growth medium, with
either 20 ,uCi of [14C]leucine, 5 ,uCi of tritiated leucine, or 3jCi of tritiated uridine per ml. After incubation at 37°C for 2
min, 1 ml of ice-cold 10% TCA was added, and those tubes
labeled with leucine were boiled for 15 min. The precipitates
were collected on Whatman GF/C filters and washed and
counted as described above.
All the results were collected for the number of viable
cells present at each time.
Transport of leucine. The transport of L-[U- 4C]leucine
(2.3 ROCi/jig) by E. coli GS7T1 was measured as described
elsewhere (5), with the following modifications. Cells grown
in M9 medium with the supplements described above were
harvested in mid-logarithmic phase of growth by centrifuga-
tion. They were suspended at a density of 3.3 x 108 CFU/ml
in the 100 mM Tris hydrochloride medium of Berger and
Heppel (5) to which 50 ,ug of thymine, 5 ,ug of L-leucine, and
2 mg of glucose per ml had been added. The cell suspension
was preincubated at 37°C with 1.6 nmol of microcin 7 per ml
for 20 min, and then the labeled amino acid was added to a
final concentration of 1 ,uCi/ml. Samples (100 ,ul) were taken
at the desired times, and the cells were collected and washed
on Millipore HAWP filters (0.45-jim pore size) with 15 ml of
10 mM Tris hydrochloride-150 mM NaCl-0.5 mM MgCl2 at
pH 7.3. The radioactivity measured in the cells was cor-
rected for the counts retained on the filters when a complete
incubation mixture plus 2% toluene was used.
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FIG. 1. Purification of microcin 7 by HPLC. A 100-,u sample
containing 30 nmol of microcin 7 in 0.1% trifluoracetic acid was
applied to a ,uBondapak-C18 columnn equilibrated with the same
solvent. Elution was performed with a gradient of acetonitrile in
0.1% trifluoroacetic acid as indicated in the figure. Other conditions
are indicated in the text.
RESULTS
Tryptic peptides. Microcin 7 was purified by HPLC as
described previously (11), until it behaved homogeneously in
several HPLC systems (Fig. 1). The amino acid composition
of the sample used in this work is shown in Table 1. This
peptide does not react with ninhydrin, indicating that its
amino end is blocked and therefore that it cannot be se-
quenced by the Edman procedure. The presence of arginine
in its amino acid composition (Table 1) and the observed
inactivation of the antimicrobial activity upon treatment
with trypsin (11) suggested that the protease could be used to
generate fragments amenable to sequential degradation.
TABLE 1. Amino acid composition of microcin 7 and its tryptic
peptidesa
Amt of amino acid present (mol/mol of peptide) in:Amino acid
Microcin 7 Ta Tb Tc Td Te
Ala 1.0 1.1 0.9 1.0
Arg 1.0 1.0 1.0
Asp 1.8 2.2 1.7 1.9
Gly 1.5 1.9 1.6 1.7
Met 0.8 0.9 0.8
Thr 0.9 0.9 0.9 0.9
The analysis of microcin 7 was repeated for each HPLC-purified batch,
and the analysis of the tryptic peptides was repeated for each of the four
digestions performed. In every case, the results did not differ from those
shown by more than 0.1 nmol for a given amino acid. From 150 nmol of
microcin 7, the yield of peptides was (in nanomoles): Ta, 5; Tb, 105; TC, 7;
Td, 103; and Te, 17.
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FIG. 2. Fractionation of the tryptic peptides from microcin 7 by
HPLC. A 100-nmol sample of the digested material was applied to a
Lichrosorb RP-18 column and eluted with a gradient of methanol in
0.1% trifluoroacetic acid as indicated in the figure. Other conditions
are described in the text.
The purified microcin was digested overnight with trypsin
as described above, and the products were fractionated by
HPLC (Fig. 2). Five amino acid-containing peaks were
obtained and were termed Ta, Tb, Tc, Td, and Te. The
amino acid composition of these peaks is given in Table 1.
The major peptides, Tb and Td, accounted for the composi-
tion of the complete microcin molecule. Three additional
peptides with low yield were also obtained, i.e., Ta, with the
same composition as Tb, and Tc and Te, which at the level
of amino acid composition are identical to Td.
Different microcin preparations yielded different Ta/Tb
ratios, but Tb was always the major fraction. The ratio of Td
to the other peptides with the same composition, Tc and Te,
did not vary with the microcin preparation but was depend-
ent on the digestion time. The kinetics of appearance of the
different tryptic fragments during the first 6 h of hydrolysis
showed that Ta, Tb, and Td appeared concomitantly with
the disappearance of the microcin 7 peak (Fig. 3), whereas
the height of the Tc And Te peaks increased gradually with
the incubation time.
Peptide Tb must come from the amino end of the mole-
cule, since it has all the arginine present and, like the native
microcin molecule, was not stained by ninhydrin on thin
layers. The sequence of Tb was further investigated by
digestion with carboxypeptidase B. The analysis of the
digestion products showed that arginine was the only nin-
hydrin-positive product present and that it was obtained
with a yield comparable to that obtained after acid hydrol-
ysis of the peptide. This result implies that the sequence of
Tb is X-Met-Arg, where X represents an acid-labile group
which blocks the amino terminus of microcin 7. The same
results were obtained with the minority peptide Ta. Addi-
tionally, we isolated from some microcin preparations a
dipeptide which, upon treatment with carboxypeptidase B,
yielded equimolar amounts of arginine and methionine sul-
foxide, indicating that during the experimental manipula-
tions, some amino termini had been unblocked and the
methionine residues Were oxidized in some molecules. To
investigate the nature of the amino-blocking group, we
I
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FIG. 3. Kinetics of tryptic hydrolysis of microcin 7. Samples (30
,ul) containing about 4 nmol of microcin 7, digested with trypsin for
variable times, were diluted with 70 ,ul of 0.2% trifluoroacetic acid
and applied to a Lichrosorb RP-18 column equilibrated with a 0.1%
solution of the same acid. Tryptic fragments were eluted with a
linear gradient of 0 to 50%o methanol in 0.1%o trifluoroacetic acid.
Numbers above the baselines indicate the digestion time in minutes.
The fractionation of N-formyl-methionylarginine (N-t) and N-ace-
tyl-methionylarginine (N-Ac) under the same conditions is also
shown in the figure (right bottom). Other conditions are indicated in
the text.
acylated the commercial dipeptide L-Met-L-Arg and chroma-
tographed the products in parallel with the tryptic digestion
products of microcin 7. Even though there were problems
with gradient reproducibility, it can be seen in Fig. 3 that the
acetylated derivative was eluted from our HPLC system
with approximately the same retention time as Ta and Tb,
whereas the formylated dipeptide had a shorter retention
time, suggesting that the blocking group may be an acetyl
moiety.
The tryptic peptides coming from the carboxy-terminal
end of the microcin molecule, namely, Tc, Td, and Te, had
a free amino termius, and they were subjected to manual and
automatic Edman degradation (Fig. 4). The composition of
the amino-terminal end of Td was confirmed by aminopep-
tidase M digestion (Table 2). In this last case, however,
quantitative liberation of the penultimate residue (Ala) did
not free the last residue (Asp) in detectable amounts. Prob-
aPbly related to this last result is the finding that Td, as well as
Tc, Te, and the complete microcin molecule, is resistant to
digestion by carboxypeptidases A, B, and Y.
Also related to the nature of the carboxy-terminal end is
the finding that in the analysis of the hydrolyzed thiazoli-
nones obtained in the last two cycles of the sequencing
procedures and in the amino acid analysis of the digestion
products obtained with aminopeptidase M, we observed two
unidentified peaks. One peak was eluted from the amino acid
analyzer slightly later than phenylalanine, and the other
peak was eluted very close to lysine.
Taken together, these results indicate that the carboxy-
terminal aspartic acid is substituted by an acid-labile group.
Tc Thr - Gly - Asn - Ala - Asx
2.8 5.9 1.2 1.2
Td Thr - Gly - Asn - Ala - Asp
20.0 25.7 8.3 5.0 8.2
Te Thr - Gly - Asn - Ala - Asx
4.5 6.0 1.9 0.5
FIG. 4. Amnino acid sequences of the carboxy-terminal tryptic
peptides from microcin 7. Numbers under the residues are yields in
nanomoles of the amino acid recovered after back hydrolysis of the
corresponding aniliniothiazolinone. The data shown are from a
representative experiment out of a total of three performed. The
presence of Asx in Tc and Te is deduced from the amino acid
composition.
This group is completely removed by acid hydrolysis. It is
also removed, although not completely, by the sequencing
procedures employed, but it remains attached after amino-
peptidase digestion.
Antimicrobial activity of microcin 7. A survey of the
sensitivity to microcin 7 of a collection of strains provided
by the Servicio de Microbiologia of the Ram6n y Cajal
Center in Madrid showed that this peptide is active against
gram-negative strains phylogenetically close to E. coli and
also against one Proteus strain (Table 3).
We have estimated the MIC of microcin 7 in different
media against E. coli GS7 and its derivative E. coli RYC25,
which carries the plasmid that codes for the expression of
this particular microcin (11). In minimal (M9), C.L.E.D.,
and Mueller-Hinton media, strain GS7 was inhibited by 0.4,
1, and 3 nmol/ml, respectively, whereas its microcinogenic
derivative could grow in the presence of as much as 32 nmol
of the peptide per ml in all media.
Mode of action of microcin 7. We have investigated the
effect of microcin 7 on the biosynthesis of mnacromolecules
in E. coli GS7T1 at its MIC, a concentration just high enough
to stop the growth of logarithmic-phase cells (Fig. 5). At this
concentration the cells retain their viability in the presence
of the microcin for at least 8 h (data not shown).
Under these conditions, the incorporation of either thy-
mine or uridine into material insoluble in 5% TCA was not
affected (Fig. 6 and 7). The incorporation of diaminopimelic
acid into material insoluble in boiling 4% sodium dodecyl
sulfate was apparently stimulated by microcin 7 (Fig. 6),
whereas the incorporation of leucine into macromolecules
was inhibited after a few minutes (Fig. 7). The lag was
reduced when the number of cells present in the assay was
lowered or when the concentration of the antibacterial agent
was raised, suggesting that the lag represented the time
TABLE 2. Amino acids released from tryptic peptide Td by
aminopeptidase M
Amino acid released (nmol) afterb:
Buffer'
24 h 48 h
Bicarbonate Thr (11.0), Gly (8.2) NDC
Phosphate Thr (2.8), Gly (2.7), Asn Thr (2.0), Gly (1.9), Asn
(2.6), Ala (2.7) (1.9), Ala (1.9)
a Conditions as described in the text.
b Yields are in nanomoles of free amino acid. The data are the results of a
single experiment.
c ND, Not determined.
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needed by the peptide to reach an intracellular concentration
high enough to produce a noticeable effect. To increase the
sensitivity of the assay, we measured the incorporation rate,
rather than the total accumulation, of labeled leucine in the
macromolecules of exponentially growing cells treated with
microcin 7. The incorporation of uridine wa,s measured at
the same time in the same cultures. We found that although
RNA synthesis proceeded unaffected, the rate of protein
synthesis decreased markedly after the first 10 min of
treatment (Fig. 7).
The possibility that the microcin might be interfering with
the transport of the precursor used to estimate protein
biosynthesis was also tested (Fig. 8). The transport of
leucine was measured at twice the concentration (per cell) of
microcin 7 used in the incorporation experiments. After 20
min in the presence of microcin, the treated cells transported
leucine at the same rate as the controls, and after the first 2
min of the assay, both cultures retained stable, comparable
levels of intracellular leucine, at least for 15 min more (data
not shown).
DISCUSSION
When a sample of microcin 7 previously found to be
homogeneous by HPLC is digested with trypsin, the mole-
cule is split mainly into an amino-terminal dipeptide (Tb) and
a carboxy-terminal pentapeptide (Td). A variable but minor
amount of another dipeptide (Ta), with the same composi-
tion as Tb, is also obtained (Table 1). The finding of
methionine sulfoxide in a microcin preparation suggests that
the purified native peptide, when kept in aqueous solutions
for long times, may be partially oxidized on its N-terminal
methionine to the corresponding sulfoxide, as has been
found in other peptides (22, 25). The oxidized amino-termi-
nal ends would correspond to the dipeptide Ta, since Ta is
the fragment that appears in smaller amounts when sample
TABLE 3. Antimicrobial activity of microcin 7a
Sensitive StrainsSpecies strains (no.) tested (no.)
E. coli 6 7
Klebsiella pneumoniae 1 2
Klebsiella oxytoca 0 1
Salmonella typhi 2 2
Salmonella typhimurium 1 1
Salmonella sp. 4 4
Shigella flexneri 1 1
Shigella sp. 2 2
Serratia marcescens 0 1
Proteus mirabilis 1 4
Proteus vulgaris 0 1
Erwinia herbicola 0 1
Pseudomonas aeruginosa 0 3
Pseudomonas maltophilia 0 1
Staphylococcus aureus 0 4
Staphylococcus epidermidis 0 1
Bacillus amyloliquefaciens 0 1
Micrococcus luteus 0 1
Streptococcus agalactiae 0 1
Candida albicans 0 1
Rhodotorula mucilaginosa 0 1
a Strains to be tested were grown as a lawn (ca. 107 cells per plate) on plates
with 25 ml of C.L.E.D. medium (Oxoid), with 1.5 nmol of microcin 7 in sterile
saline deposited into a central well. After 15 h of incubation at 37°C, the plates
were scored for the presence or absence of a clearly visible inhibition zone
around the central well.
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FIG. 5. Effect of microcin 7 on the growth of E. coli GS7T1. Two
6-ml cultures of E. coli GS7T1, growing exponentially in the minimal
medium described in the text, were incubated in 125-ml Erlenmeyer
flasks at 37°C with vigorous agitation. At zero time, the cell density
was 1.8 x 108 CFUIml, and then one of the cultures received 0.4
nmol of microcin 7 per ml (0) and the other culture was kept as a
control (0). The growth of both cultures was followed by measuring
OD6w.
handling is minimized and that has the shorter retention time
in reverse-phase HPLC (Fig. 2).
The peptide from the carboxy-terminal side of microcin 7,
Td, if left for long times in the tryptic digestion mixture,
undergoes secondary modifications that yield two other
molecular species, Tc and Te, with the same amino acid
sequence but separable by HPLC (Fig. 3 and 4). The
simplest explanation for this change is that the Asx residues
are undergoing a,,B-rearrangements, which are known to
occur easily in small peptides (6, 20, 23). Such a change
would also explain the sharp drop in yield observed at the
asparagine residue during sequencing (Fig. 4) and the block-
ade of aminopeptidase action at the same point under some
conditions (Table 2).
From the data obtained on the structure of the tryptic
peptides from microcin 7, we propose the following se-
quence for the native molecule: acetyl-Met-Arg-Thr-Gly-
Asn-Ala-Asp-X, where X symbolizes an unidentified, acid-
labile group that substitutes the terminal aspartic acid. This
blocking group is probably small or at least cannot be very
hydrophobic, given the chromatographic properties of the
native peptide (11) and its tryptic fragments (Fig. 2 and 3).
We think that this substituent is the reason for the resistance
ofthese molecules to carboxypeptidase digestion (see above).
The structure of the unidentified moiety may be related to
glycine, since a high amount of that amino acid was found in
all the analyses of either the intact microcin or the three
tryptic pentapeptides (Table 1). In our experience, the
amount of glycine found is not high enough to imply the
presence of two glycine residues per molecule (a possibility
also ruled out by the results of the sequencing experiments),
but the amount of glycine is higher than expected from a
peptide with just one glycine in its structure.
Since all the amino acids in microcin 7, except those
located at both ends, are recognized as substrates by pro-
teases considered to be of L specificity, the peptide probably
has an all-L configuration, although it should be kept in mind
that we have used high enzyme/substrate ratios and long
incubation times in those experiments.
The most studied peptide antibiotics are synthesized by
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FIG. 6. Effect of microcin 7 on the incorporation of precursors
into DNA (A) and cell wall (B). E. coli GS7T1 was grown under the
conditions described in the text. The labeled precursors were added
at zero time, either alone (0) or with a final concentration of 0.4
nmol of microcin 7 per ml (0). Each point represents the average of
two samples. (A) Incorporation of tritiated thymine (50 jig and 10
pCi/ml) into materials precipitable by 5% TCA. (B) Incorporation of
tritiated diaminopimelic acid (DAP; 10 ,ug and 10 gCi/ml) into
material insoluble in 4% sodium dodecyl sulfate.
nonribosomal mechanisms and they include D amino acids in
their structures. Although microcin 7 resembles a short
gramicidin (16), it does not have the configuration or the
mechanism of action (see above) of those antibiotics. Our
hypothesis is that microcin 7 may be the result of the
enzymatic modification of some cellular peptide, perhaps of
a cleaved signal peptide, to which it has some resemblance
(7). The relationship between a secreted microbial peptide
and signal sequences has been suggested before (10, 27).
This hypothesis of an enzymatic processing of a cellular
precursor would also account for the large amount of DNA
found to be necessary for the expression of microcin 7 (4).
Most peptide antibiotics and many colicins disrupt the
permeability barrier of the cell membrane, thereby abolish-
ing all macromolecular biosynthesis within seconds. Micro-
cin 7 seems to inhibit only the incorporation of amino acids
into proteins (Fig. 7). The observed stimulation of cell wall
synthesis (Fig. 6) agrees with the described effect of inhibi-
tors of protein synthesis on relA strains (14).
The data so far obtained did not permit us to classify this
antibacterial agent, produced by a common resident of the
human intestine, either as a bacteriocin or as a peptide
antibiotic. Its small size, bacteriostatic mode of action, and
production kinetics (11) resemble those of the antibiotics
produced by secondary metabolism. However, other prop-
erties of microcin 7 resemble the properties of bacteriocins.
These properties include the spectrum of antibacterial activ-
ity centered on the phylogenetic relatives of the producer
strain, composition (L amino acids), and the fact that there
exists a specific immunity to this antibacterial agent that is
coded for in the same plasmid that codes for the expression
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FIG. 7. Effect of microcin 7 on the incorporation rate of uridine
(A) and leucine (B) into macromolecules. An exponentially growing
culture of E. coli GS7T1 was divided into two subcultures. One
culture received microcin 7 at a final concentration of 0.4 nmol/ml
(0). The other culture was kept as it control (0).' Samples from both
cultures were pulse-labeled for 2 min with tritiated uridine (20 p,g
and 0.3 pCi/ml) or with (14C]leucine (10 p.g and 2 ,uCi/ml) as
described in the text. Each point represents the average of two
samples.
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FIG. 8. Effect of microcin 7 on leucine uptake by E. coli GS7T1.
The cells were grown, harvested, and suspended as described in the
text. Fractions (0.4 ml) of the cell suspension were preincubated at
370C in tubes containing either 10 ,ul of sterile water (0) or 0.8 nmol
of microcin 7 in 10 ,ul of water (0). After 10 min, 20 ,ug of
chloramphenicol was added to each tube, and some of the tube6 also
received 0.25 ,umol of sodium arsenate as a positive control (A).
After 10 min more, the volume of each tube was adjusted to 0.5 ml
with prewarmed medium, and 0.5 ,uCi of ['4C]leucine was added.
Samples were taken and processed as described in the text. Each
point represents the average of two experiments performed consec-
utively with the same cell suspension.
of the antibiotic activity (4). Additional studies on the
biosynthetic mechanism involved and the mode of export
from the cells to the medium should help to clarify this
question.
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